Clinical trial

Antiviral Clinical Trial for Long Covid-19

NCT06511063

StatusRECRUITING

Study typeINTERVENTIONAL

Start date2024-10-01

PhasePHASE2

Study timeline

Study start (actual)2024-10-01Date precision: day

Registry last updated2026-03-13

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Long Covidunresolved

Interventions

tenofovir disoproxil/emtricitabineDRUG

SelzentryDRUG · verified · RxNorm: Selzentry

PlaceboDRUG

Sponsors & collaborators

Icahn School of Medicine at Mount Sinailead sponsor

Yale Universitycollaborator

PolyBio Research Foundationcollaborator

Mapped research locations

New YorkNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06511063 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.